Downregulation of Retinal Connexin 43 in GFAP-Expressing Cells Modifies Vasoreactivity Induced by Perfusion Ocular Pressure Changes.


Journal

Investigative ophthalmology & visual science
ISSN: 1552-5783
Titre abrégé: Invest Ophthalmol Vis Sci
Pays: United States
ID NLM: 7703701

Informations de publication

Date de publication:
04 01 2021
Historique:
entrez: 27 1 2021
pubmed: 28 1 2021
medline: 12 6 2021
Statut: ppublish

Résumé

Glia and their communication via connexin 43 (Cx43) gap junctions are known to mediate neurovascular coupling, a process driven by metabolic demand. However, it is unclear whether Cx43 mediated glial communication intermediates classical autoregulation. Here we used viral transfection and a glial fibrillary acidic protein (GFAP) promoter to downregulate glial Cx43 to evaluate its role in retinal vascular autoregulation to ocular perfusion pressure (OPP) reduction. Adult rats were intravitreally injected with the viral active construct or a control. Three weeks after the injection, eyes were imaged using confocal scanning laser ophthalmoscopy before and during a period of OPP decrease induced by blood draw to lower blood pressure or by manometric IOP elevation. Vessel diameter responses to the OPP decrease were compared between Cx43-downregulated and control-injected eyes. The extent of Cx43 downregulation was evaluated by Western blot and immunohistochemistry. In control eyes, the OPP decrease induced dilatation of arterioles, but not venules. In Cx43-downregulated eyes, Cx43 expression in whole retina was decreased by approximately 40%. In these eyes, the resting diameter of the venules increased significantly, but there was no effect on arterioles. In Cx43-downregulated eyes, vasoreactivity evoked by blood pressure lowering was significantly compromised in both arterioles (P = 0.005) and venules (P = 0.001). Cx43 downregulation did not affect the arteriole responses to IOP elevation, whereas the responses of the venules showed a significantly greater decrease in diameter (P < 0.001). The downregulation of retinal Cx43 in GFAP-expressing cells compromises vasoreactivity of both arterioles and venules in response to an OPP decrease achieved via blood pressure lowering or IOP elevation. The results also suggest that Cx43-mediated glial communication actively regulates resting venular diameter.

Identifiants

pubmed: 33502459
pii: 2772223
doi: 10.1167/iovs.62.1.26
pmc: PMC7846954
doi:

Substances chimiques

Connexin 43 0
GFAP protein, rat 0
Gja1 protein, rat 0
Glial Fibrillary Acidic Protein 0

Types de publication

Journal Article Research Support, N.I.H., Extramural Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

26

Subventions

Organisme : NEI NIH HHS
ID : R01 EY019939
Pays : United States

Références

Graefes Arch Clin Exp Ophthalmol. 1997 Oct;235(10):618-26
pubmed: 9349945
PLoS One. 2013 Sep 27;8(9):e76310
pubmed: 24086725
Nature. 2020 Sep;585(7823):91-95
pubmed: 32788726
Invest Ophthalmol Vis Sci. 2012 Jun 20;53(7):3726-32
pubmed: 22589427
Physiol Rev. 2006 Jul;86(3):1009-31
pubmed: 16816144
Biomed Res Int. 2016;2016:2954721
pubmed: 27294114
Invest Ophthalmol Vis Sci. 2011 Apr 05;52(5):2153-9
pubmed: 21220555
J Neurosci. 2015 May 27;35(21):8245-57
pubmed: 26019339
Exp Eye Res. 2004 Sep;79(3):423-9
pubmed: 15336506
Antioxid Redox Signal. 2009 Feb;11(2):267-82
pubmed: 18834327
Am J Physiol Cell Physiol. 2017 Oct 1;313(4):C362-C370
pubmed: 28974518
Science. 2001 May 4;292(5518):872-3
pubmed: 11341285
Panminerva Med. 2017 Mar;59(1):76-89
pubmed: 27598891
J Neurosurg. 2014 Mar;120(3):628-38
pubmed: 24266544
Neuroscience. 1999;92(1):255-65
pubmed: 10392848
Optom Vis Sci. 2019 Jul;96(7):470-476
pubmed: 31274734
J Neurosci. 2015 Sep 30;35(39):13463-74
pubmed: 26424891
Nature. 2010 Nov 11;468(7321):232-43
pubmed: 21068832
Glia. 2006 Nov 15;54(7):716-25
pubmed: 17006900
PLoS One. 2014 Dec 11;9(12):e114546
pubmed: 25501362
Acta Neurol Belg. 2004 Jun;104(2):51-6
pubmed: 15508267
PLoS One. 2010 Aug 24;5(8):e12387
pubmed: 20808778
Microvasc Res. 2015 Sep;101:86-95
pubmed: 26186381
Trends Neurosci. 2013 Jul;36(7):405-17
pubmed: 23659852
Philos Trans R Soc Lond B Biol Sci. 2015 Jul 5;370(1672):
pubmed: 26009774
Nat Methods. 2012 Jun 28;9(7):676-82
pubmed: 22743772
Clin Sci (Lond). 1999 Apr;96(4):313-26
pubmed: 10087237
Physiol Rep. 2013 Aug;1(3):e00055
pubmed: 24303137
Surv Ophthalmol. 1994 Jul-Aug;39(1):23-42
pubmed: 7974188
Epilepsia. 2011 Mar;52(3):589-601
pubmed: 21275977
Invest Ophthalmol Vis Sci. 2017 Jan 1;58(1):1-8
pubmed: 28055098
Glia. 1997 May;20(1):10-22
pubmed: 9145301
Clin Exp Ophthalmol. 2001 Jun;29(3):167-70
pubmed: 11446461
Arch Mal Coeur Vaiss. 2005 Sep;98(9):913-21
pubmed: 16231579
Exp Eye Res. 2010 Feb;90(2):203-9
pubmed: 19853603
Prog Retin Eye Res. 2016 Mar;51:41-68
pubmed: 26432657
J Glaucoma. 1996 Oct;5(5):308-10
pubmed: 8897229
Front Neuroenergetics. 2013 Apr 26;5:4
pubmed: 23637659
Invest Ophthalmol Vis Sci. 2014 May 29;55(7):4105-18
pubmed: 24876284
Compr Physiol. 2012 Jul;2(3):1981-2035
pubmed: 23723031
J Comp Neurol. 2003 Jan 20;455(4):531-46
pubmed: 12508325
Invest Ophthalmol Vis Sci. 2015 Nov;56(12):7551-9
pubmed: 26618647
Vis Neurosci. 2006 Jan-Feb;23(1):1-10
pubmed: 16597346
Invest Ophthalmol Vis Sci. 2016 Feb;57(2):412-9
pubmed: 26848880
Nature. 2009 Feb 5;457(7230):675-7
pubmed: 19194443
Invest Ophthalmol Vis Sci. 1994 Mar;35(3):1019-25
pubmed: 8125712
Microvasc Res. 1997 May;53(3):211-21
pubmed: 9211399
Biomed Opt Express. 2012 Sep 1;3(9):2220-33
pubmed: 23024915
J Comp Neurol. 1991 Nov 22;313(4):587-603
pubmed: 1783683
Ophthalmic Physiol Opt. 2015 Mar;35(2):114-24
pubmed: 25528886
PLoS One. 2017 Dec 15;12(12):e0188830
pubmed: 29244806
Microcirculation. 1996 Sep;3(3):263-70
pubmed: 8930883
Am J Physiol Heart Circ Physiol. 2008 Jun;294(6):H2855-63
pubmed: 18456724
Biomed Opt Express. 2013 Feb 1;4(2):364-86
pubmed: 23412846

Auteurs

Guodong Liu (G)

Department of Ophthalmology, Shanghai Tenth People's Hospital, Shanghai, China.
Devers Eye Institute, Legacy Research Institute, Portland, Oregon, United States.

Hui Li (H)

Department of Ophthalmology, Shanghai Tenth People's Hospital, Shanghai, China.
Devers Eye Institute, Legacy Research Institute, Portland, Oregon, United States.

Grant Cull (G)

Devers Eye Institute, Legacy Research Institute, Portland, Oregon, United States.

Laura Wilsey (L)

Devers Eye Institute, Legacy Research Institute, Portland, Oregon, United States.

Hongli Yang (H)

Devers Eye Institute, Legacy Research Institute, Portland, Oregon, United States.

Jesica Reemmer (J)

RS Dow Neurobiology, Department of Translational Neuroscience, Legacy Research Institute, Portland, Oregon, United States.

Hai-Ying Shen (HY)

RS Dow Neurobiology, Department of Translational Neuroscience, Legacy Research Institute, Portland, Oregon, United States.

Fang Wang (F)

Department of Ophthalmology, Shanghai Tenth People's Hospital, Shanghai, China.

Brad Fortune (B)

Devers Eye Institute, Legacy Research Institute, Portland, Oregon, United States.

Bang V Bui (BV)

Department of Optometry and Vision Sciences, University of Melbourne, Parkville, Victoria, Australia.

Lin Wang (L)

Devers Eye Institute, Legacy Research Institute, Portland, Oregon, United States.

Articles similaires

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male
Humans Meals Time Factors Female Adult

Classifications MeSH